Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack survivors get a buddy: new program aims to keep them moving

NCT ID NCT05927363

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

After a heart attack, cardiac rehab helps patients get active, but many stop exercising within a year. This completed trial tested a program where a 'patient partner' (a fellow heart patient) and a healthcare professional provided support through two teleconsultation sessions over 4 months. The goal was to see if this approach helped 84 heart attack survivors maintain moderate-to-vigorous physical activity, measured by an accelerometer, compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
therapeutic educational consolidation program with a patient partner and caregiver
What this could lead to
If successful, this program could offer a simple way to help heart attack survivors maintain physical activity long-term, reducing their risk of future heart problems.
What could go wrong
This is a small, completed study (84 participants) that measured activity levels at 6 months. The results may not apply to all patients, and the program requires internet access and French fluency.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

Jan 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient of legal age (≥ 18 years). * Patient having undergone phase 2 treatment in the cardiovascular rehabilitation department of the CHU for myocardial infarction. * Patient with a means of communication that allows easy internet connection (i.e. a smartphone). * Patient fluent in French. * Patient who has given free informed consent. * Patient affiliated or beneficiary of a health insurance scheme. Exclusion Criteria: * Patient with severe or unstable comorbidity (respiratory insufficiency renal failure, decompensated heart failure). heart failure). * Patient with unstable angina. * Patient with contraindications to physical activity following physical activity following cardiovascular rehabilitation (according to medical discussion, based on the recommendations of the French Society of Cardiology). * Patient with no suitable means of communication. * Patient under court protection, guardianship or curatorship. * Pregnant, parturient or breast-feeding patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction

Contacts and locations

Locations

  • CHU de Nîmes

    Nîmes, 30900, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.